Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 20/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27193700 | 0.88 | FFAR1 (0.75) | FFAR1 | |
| SCHEMBL27273767 | 0.88 | FFAR1 (0.75) | FFAR1 | |
| SCHEMBL27193328 | 0.88 | FFAR1 (0.75) | FFAR1 | |
| SCHEMBL24646840 | 0.88 | FFAR1 (0.75) | FFAR1 | |
| SCHEMBL30312238 | 0.88 | FFAR1 (0.75) | FFAR1 | |
| SCHEMBL27193330 | 0.88 | FFAR1 (0.75) | FFAR1 | |
| SCHEMBL24645984 | 0.88 | FFAR1 (0.75) | FFAR1 | |
| SCHEMBL24645974 | 0.88 | FFAR1 (0.75) | FFAR1 | |
| SCHEMBL21644820 | 0.87 | FFAR1 (0.77) | FFAR1CYP3A4CYP2C8 | |
| SCHEMBL21688301 | 0.87 | FFAR1 (0.77) | FFAR1CYP3A4CYP2C8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220289772-A1 | GPR40 AGONISTS | KALLYOPE, INC. | 2022-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220289772-A1 | GPR40 AGONISTS | GPR119, GPR65, GLP1R | FFAR1 10/4885CYP3A4 1300/4885CYP2C8 1737/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.